Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Long-acting GLP-1 receptor agonist injections are more effective at reducing HbA1c levels in diabetes patients than gliptins when added to metformin, say European researchers.
Their meta-analysis looked at 21 studies into incretin-based therapy as an add-on to metformin for 16-30 weeks, compared with short-acting GLP-1 receptor agonists or DPP-4 inhibitors.
http://www.pulsetoday.co.uk/newsart...in-injections-reduce-hba1c-more-than-gliptins
(free regitration required)
Their meta-analysis looked at 21 studies into incretin-based therapy as an add-on to metformin for 16-30 weeks, compared with short-acting GLP-1 receptor agonists or DPP-4 inhibitors.
http://www.pulsetoday.co.uk/newsart...in-injections-reduce-hba1c-more-than-gliptins
(free regitration required)